Atovaquone and Hepatic function abnormal - a phase IV clinical study of FDA data

Summary:

Hepatic function abnormal is reported as a side effect among people who take Atovaquone (atovaquone), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Prednisolone, and have Hiv infection.

The phase IV clinical study analyzes which people have Hepatic function abnormal when taking Atovaquone. It is created by eHealthMe based on reports of 5,778 people who have side effects when taking Atovaquone from the FDA, and is updated regularly.

What is Atovaquone?

Atovaquone has active ingredients of atovaquone. eHealthMe is studying from 5,786 Atovaquone users. Check the latest studies of Atovaquone.

What is Hepatic function abnormal?

Hepatic function abnormal is found to be associated with 1,436 drugs and 2,021 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

5,778 people reported to have side effects when taking Atovaquone.
Among them, 66 people (1.14%) have Hepatic function abnormal.

Could Atovaquone cause Hepatic function abnormal?

Among these 66 people:

How long have people been on Atovaquone when they have Hepatic function abnormal? *

What is the gender of people who have Hepatic function abnormal when taking Atovaquone? *

female: 25.93 %
male: 74.07 %

What is the age of people who have Hepatic function abnormal when taking Atovaquone? *

What are other drugs people take besides Atovaquone? *

What are other side effects people have besides Hepatic function abnormal? *

Renal Impairment (severely reduced kidney function): 12 people, 18.18%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 12 people, 18.18%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 10 people, 15.15%
Drug Eruption (adverse drug reaction of the skin): 9 people, 13.64%
Anaemia (lack of blood): 8 people, 12.12%
Drug Hypersensitivity: 8 people, 12.12%
Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 8 people, 12.12%
Upper Respiratory Tract Inflammation: 8 people, 12.12%
Low Density Lipoprotein Increased (cholesterol increased in blood): 7 people, 10.61%
Rashes (redness): 7 people, 10.61%

What are the existing conditions these people have? *

Hiv Infection: 12 people, 18.18%
Pneumonia: 10 people, 15.15%
Cytomegalovirus Infection: 9 people, 13.64%
Constipation: 9 people, 13.64%
Osteoporosis (bones weak and more likely to break): 9 people, 13.64%
Infection: 8 people, 12.12%
Non-Small Cell Lung Cancer Stage Iv: 7 people, 10.61%
Pulmonary Mycosis (lung infection caused by yeast-like fungi): 7 people, 10.61%
Nausea (feeling of having an urge to vomit): 6 people, 9.09%
Lung Neoplasm Malignant (cancer tumour of lung): 6 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Atovaquone and have Hepatic function abnormal?

- Check whether Hepatic function abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atovaquone:

Atovaquone (5,786 reports)

Browse all side effects of Atovaquone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic function abnormal:

Hepatic function abnormal (1,436 drugs)

Browse all the conditions that are associated with Hepatic function abnormal:

Hepatic function abnormal (2,021 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atovaquone (the active ingredients of Atovaquone) and Atovaquone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.